Warfarin resistance: possibilities to solve this problem. A case report [PDF]
Journal of International Medical Research, 2022 Effective prevention of thromboembolism is essential for patients with mechanical prosthetic heart valves. For this group of patients, vitamin K antagonists (VKAs) remain the drug group of choice despite the widespread use of new anticoagulants in other ...
Halyna Mostbauer +3 more
doaj +2 more sources
One Rare Warfarin Resistance Case and Possible Mechanism Exploration [PDF]
Pharmacogenomics and Personalized Medicine, 2023 Li Zhao,1 Zhenguo Zhai,2 Pengmei Li1 1Pharmacy Department, China-Japan Friendship Hospital, Beijing, People’s Republic of China; 2Department of Respiratory and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, People’s Republic of ...
Zhao L, Zhai Z, Li P
doaj +2 more sources
Genetic Warfarin-Resistance Resulting in Surgery to Change a Prosthetic Valve [PDF]
European Journal of Case Reports in Internal Medicine, 2020 Warfarin is a readily available anticoagulant used worldwide in a variety of clinical scenarios. Patients who need more than 15 mg/day are considered to be warfarin resistant.
Jahanzeb Malik +4 more
doaj +2 more sources
Ascorbic acid-induced warfarin resistance after breast cancer surgery: a case report and literature review [PDF]
Frontiers in PharmacologyWarfarin is an anticoagulant that requires INR-based dosage adjustment. Ascorbic acid may impair warfarin effectiveness according to limited literature.
Pingfa Gao +4 more
doaj +2 more sources
A Chinese patient with cardiogenic stroke and warfarin resistance: a case report [PDF]
BMC NeurologyBackground Warfarin is the most commonly used oral anticoagulant drug in clinical practice due to its effective anticoagulant effect and low cost. Warfarin plays a crucial role in the anticoagulant treatment of patients with thrombotic diseases such as ...
Xiaoyan Du +6 more
doaj +2 more sources
Anticoagulation Therapies and microRNAs in Heart Failure [PDF]
BiomoleculesHeart Failure (HF) remains a major cause of mortality despite the advances in pharmacological treatment. Anticoagulation therapies, including Clopidogrel, Aspirin, Warfarin, and novel oral anticoagulants (NOACs) such as Apixaban, Rivaroxaban, Edoxaban ...
Lucia Spartano +2 more
doaj +2 more sources
Warfarin resistance: interaction between warfarin and Eruca sativa L.
Swiss Medical Weekly, 2006 [Abstract Not Available]
M Goz, F Goz, O Cakir, B Aydinol, N Eren
doaj +3 more sources
Warfarin Resistance: A Case Report
Eurasian Journal of Emergency Medicine, 2019 Warfarin is the most widely prescribed anticoagulant in the world. Patients who need more than 15 mg per day should be considered warfarin-resistant.
Uğur Gönlügür +3 more
doaj +3 more sources
Warfarin Resistance, a Case Report [PDF]
Journal of Cardiovascular and Thoracic Research, 2010 In tolerance to oral anticoagulant drugs may arise as an inborn genetic defect resulting in insensitive hepatic receptor sites to oral anticoagulants or it may be due to one of several acquired causes such as noningestion or malabsorption of the drugs ...
Rezayat Parvizi +2 more
doaj +1 more source
Antiphospholipid syndrome presents with aortic thrombosis and central venous catheter-related thrombosis: a case report [PDF]
Thrombosis JournalBackground Antiphospholipid syndrome (APS) is a prothrombotic autoimmune disorder in which perioperative factors—particularly cardiopulmonary bypass—may amplify hypercoagulability.
Yujiao Chen +3 more
doaj +2 more sources